A comprehensive view of prescription drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca selects SAS to aid automation and boost efficiency in delivery of statistical analyses for clinical and post-approval submissions to regulatory authorities using SAS’s cloud-based software and technologies
Published: September 28, 2023 by PharmaTimes
Study of healthcare professionals in US, France, UK finds 80% of HCPs distrust pharma digital content amidst concerns of data cherry-picking and lack of comprehensive assessments; professionals in UK have least favorable view of pharma: Graphite Digital
Published: September 28, 2023 by FiercePharma
AstraZeneca, Bristol Myers Squibb, and Merck to participate in the first round of drug price negotiations under the Inflation Reduction Act; J&J, Novartis, Lilly, Novo Nordisk, and Amgen yet to declare their stance
Published: September 28, 2023 by FiercePharma
Publix will now offer cheaper prescription medications via pharmacy program company Visory Health, which does not require insurance; shoppers are able to use the Visory app at Publix stores to receive their discounts
Published: September 26, 2023 by Supermarket News
GlobalData expects psychedelic drug market to hit US$7.2B by 2029, reflecting 55% CAGR and driven by positive regulatory changes; by 2029, top drugs expected to be Atai Life Sciences/Otsuka Pharmaceutical's PCN-101, Cybin's CYB-003, Small Pharma's SPL-026
Published: September 26, 2023 by GlobalData Plc

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count